Papers
10
Total Citations
67
H-Index
5
About
Andres Correa is a leading urologic oncologist whose research centers on the surgical management of upper tract urothelial carcinoma (UTUC), kidney cancer, and penile cancer. He is a key figure in the ROBUUST 2.0 collaborative group, which has produced landmark studies on robot-assisted nephroureterectomy (RANU) involving over 1,100 patients, establishing benchmarks for surgical and mid-term oncological outcomes. His work has clarified the prognostic impact of diagnostic ureteroscopy, the importance of bladder cuff excision, and the role of adjuvant immunotherapy in high-risk UTUC. Correa has also advanced the technical management of inguinal lymphadenectomy in penile cancer, comparing open and minimally invasive approaches, and has investigated functional outcomes of robotic versus open partial nephrectomy in patients with pre-existing chronic kidney disease. His contributions include developing a nomogram to predict muscle invasion in UTUC and evaluating single-dose intravesical chemotherapy after RANU. With multiple publications in high-impact journals and ongoing leadership in multi-institutional registries, Correa’s research directly shapes clinical decision-making and improves outcomes for patients with complex urologic malignancies.
Research Focus
Key Achievements
Top Papers
- 1
- 2
- 3
- 4
- 5
- 6
- 7
- 8
- 9
- 10